Parnate

Krajina: Nový Zéland

Jazyk: angličtina

Zdroj: Medsafe (Medicines Safety Authority)

Aktívna zložka:

Tranylcypromine sulfate 13.68mg equivalent to 10 mg tranylcypromine; Tranylcypromine sulfate 13.68mg equivalent to 10 mg tranylcypromine

Dostupné z:

Boucher & Muir (NZ) Ltd t/a Mercury Pharma (NZ)

INN (Medzinárodný Name):

Tranylcypromine sulfate 13.68 mg (=10 mg tranylcypromine)

Dávkovanie:

10 mg

Forma lieku:

Film coated tablet

Zloženie:

Active: Tranylcypromine sulfate 13.68mg equivalent to 10 mg tranylcypromine Excipient: Calcium sulfate Carnauba wax Red Spectraspray ACSL0673 Erythrosine Gelatin Hypromellose Magnesium stearate Maize starch Propylene glycol Shellac Sucrose Active: Tranylcypromine sulfate 13.68mg equivalent to 10 mg tranylcypromine Excipient: Calcium sulfate Carnauba wax Erythrosine Gelatin Magnesium stearate Maize starch Opadry red 06H250000 Sucrose

Počet v balení:

Blister pack, 50 tablets

Trieda:

Prescription

Typ predpisu:

Prescription

Výrobca:

Trifarma SpA

Terapeutické indikácie:

Parnate is indicated for the treatment of symptoms of depressive illness especially where treatment with other types of anti-depressants has failed. It is not recommended for use in mild depressive states resulting from temporary situational difficulties.

Prehľad produktov:

Package - Contents - Shelf Life: Blister pack, - 50 tablets - 36 months from date of manufacture stored at or below 25°C

Dátum Autorizácia:

1969-12-31

Príbalový leták

PARNATE CONSUMER MEDICINE INFORMATION
Page 1 of 10
PARNATE
® TABLETS
(Tranylcypromine 10 mg)
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some of the common questions about Parnate. It
does not contain all the
available information. It does not take the place of talking to your
doctor or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the
risks of you taking
Parnate against the benefits they expect it will have for you.
IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR
OR PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT PARNATE IS USED FOR
Parnate is used to treat symptoms of depression, especially if
treatment with other types of
antidepressants has failed. There are many different types of
medicines used to treat
depression. Parnate belongs to a group of medicines called monoamine
oxidase inhibitor
(MAOI) antidepressants. It contains the active ingredient
tranylcypromine.
Depression is longer lasting or more severe than the ‘low moods’
that everyone has from time
to time. It is thought to be caused by a chemical imbalance in parts
of the brain. The
imbalance affects your whole body and can cause emotional and physical
symptoms. You
may feel low in spirit, lose interest in usual activities, be unable
to enjoy life, have poor
appetite or overeat, have disturbed sleep, often waking up early, low
energy and feel guilty
over nothing.
Parnate corrects the chemical imbalance and helps relieve the symptoms
of depression. It is
not recommended for the ‘low moods’ that everyone has from time to
time due to the stress or
sadness of everyday life.
Your doctor may have prescribed Parnate for another use.
ASK YOUR DOCTOR IF YOU HAVE QUESTIONS ABOUT WHY PARNATE HAS BEEN
PRESCRIBED FOR YOU.
Parnate is available only with a doctor’s prescription.
PARNATE CONSUMER MEDICINE INFORMATION
Page 2 of 10
BEFORE YOU TAKE PARNATE
_WHEN YOU MUST NOT TAKE IT _
DO NOT TAKE PARNATE IF YOU HAVE AN ALLERGY TO:
•
Parnate

Súhrn charakteristických

1
PARNATE
TRANYLCYPROMINE FILM-COATED TABLETS 10 MG
1
NEW ZEALAND DATA SHEET
1
PARNATE
® (10 MG FILM-COATED TABLETS)
PARNATE
10 mg film-coated tablets.
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Parnate 10 mg film-coated tablets: each tablet contains
tranylcypromine sulfate
equivalent to 10 mg of tranylcypromine.
EXCIPIENTS WITH KNOWN EFFECT:
each tablet contains sucrose 6 mg.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Parnate 10 mg film-coated tablets contain "geranium rose" coloured,
biconvex,
film-coated tablets.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Parnate is indicated for the treatment of symptoms of depressive
illness especially
where treatment with other types of anti-depressants has failed. It is
not recommended
for use in mild depressive states resulting from temporary situational
difficulties.
4.2
DOSE AND METHOD OF ADMINISTRATION
ADULTS
Begin with 20 mg a day given as 10 mg in the morning and 10 mg in the
afternoon. If
there is no satisfactory response after two weeks, add one more tablet
at midday.
Continue this dosage for at least a week. A dosage of 3 tablets a day
should only be
exceeded with caution. When a satisfactory response is established,
dosage may be
reduced to a maintenance level. Some patients will be maintained on 20
mg per day,
some will need only 10 mg daily. If no improvement occurs, continued
administration
is unlikely to be beneficial.
2
PARNATE
TRANYLCYPROMINE FILM-COATED TABLETS 10 MG
2
When given together with a tranquilliser, the dosage of Parnate is not
affected. When
the medicine is given concurrently with electroconvulsive therapy, the
recommended
dosage is 10 mg twice a day during the series and 10 mg a day
afterwards as
maintenance therapy.
Refer to section 4.4 Special warnings and precautions for use -
Stopping treatment
section.
Special populations
_Elderly_
Parnate should not be administered to adults older than 60 years of
age. Refer to
section 4.3.
Paediatric population
Parnate is not indicated for children under 18 years of